Louis Lehot Quoted in Law360 on CoreWeave IPO and 2025 IPO Outlook
March 28, 2025
Law360
Foley & Lardner LLP partner Louis Lehot was recently quoted in the Law360 article, “AI Startup CoreWeave’s Tepid Debut Chills IPO Enthusiasm. ” The article discusses the “skittish” debut for CoreWeave following a scaled-down IPO and what this could mean for the overall market moving forward.
Lehot told Law360 that he has put off expectations for a rebound until at least May. He described CoreWeave’s debut as a “bad augur,” but added that he isn’t ready to write off 2025. “There is a backlog of superb, high-quality companies ready to go public,” Lehot said.
(Subscription required)
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.